位置:首页 > 产品库 > Adrenic Acid(cis-7,10,13,16-Docosatetraenoic acid)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Adrenic Acid(cis-7,10,13,16-Docosatetraenoic acid)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Adrenic Acid(cis-7,10,13,16-Docosatetraenoic acid)图片
CAS NO:28874-58-0
包装:10mg
规格:98%
市场价:801元
分子量:332.53

AdrenicAcid是一种非酒精性脂肪肝的炎症增强剂。
CAS:28874-58-0
分子式:C22H36O2
分子量:332.53
纯度:98%
存储:Store at -20°C

Background:

Adrenic Acid is an inflammation enhancer in non-alcoholic fatty liver disease.


Adrenic acid is produced via the elongation of arachidonic acid by ELOVL2 and 5. Interestingly, the hepatic level of free Adrenic Acid (22:4n6) is markedly higher in the CDAHFD-fed db/db mice than in the SD-fed db/db mice. In plasma, the difference in the adrenic acid level reaches statistical significance (p<0.001). It is also found that the concentrations of phospholipid species containing Adrenic Acid, such as PC or PE (40:4) (containing side chain 18:0/22:4), and LPC 22:4 (sn-1/sn-2), are also significantly increased. (sn-1/sn-2). The hepatic and plasma levels of Adrenic Acid, which is an omega 6 polyunsaturated fatty acid (PUFA), exhibit greater differences between the CDAHFD-fed db/db mice and the SD-fed db/db mice (8.6-fold higher vs. 1.6-fold higher in liver tissue, 5.3-fold higher vs. 2.2-fold higher in plasma) than those of well-known proinflammatory PUFA, such as Arachidonic Acid[1].



[1]. SautHoras H Nababan, et al. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. Arch Biochem Biophys. 2017 Jun 1;623-624:64-75.


 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024